# CanSino Biologics Inc. (CASBF)

> Healthcare · CN · Reports in CNY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CASBF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ¥ 546.53M | ¥ -496.6K | ¥ -121.39M | ¥ 980.03M | ¥ 4.98B |
| 2025 | ¥ 1.06B | ¥ 27.66M | ¥ -130.05M | ¥ 1.29B | ¥ 4.96B |
| 2024 | ¥ 832.34M | ¥ -380.72M | ¥ -585.18M | ¥ 2.01B | ¥ 4.91B |
| 2023 | ¥ 355.25M | ¥ -1.49B | ¥ -1.47B | ¥ 2.70B | ¥ 5.27B |
| 2022 | ¥ 1.03B | ¥ -912.07M | ¥ -2.88B | ¥ 2.70B | ¥ 6.75B |
| 2021 | ¥ 4.38B | ¥ 1.95B | ¥ 911.12M | ¥ 1.37B | ¥ 8.00B |
| 2020 | ¥ 25.77M | ¥ -410.69M | ¥ -660.83M | ¥ 142.54M | ¥ 6.07B |
| 2019 | ¥ 2.37M | ¥ -162.77M | ¥ -281.54M | ¥ 166.80M | ¥ 1.47B |
| 2018 | ¥ 9.38M | ¥ -149.90M | ¥ -296.01M | ¥ 150.00M | ¥ 502.32M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.20 |
| Liabilities / Eq | 0.33 |
| Current Ratio | 4.39 |

## Other views

- [Metrics](https://sponda.capital/en/CASBF.md)
- [Charts](https://sponda.capital/en/CASBF/charts.md)
- [Compare](https://sponda.capital/en/CASBF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.